Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bayle

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|September 2, 2009
Dramatic improvement of glucose control after plasmapheresis and prednisone in a patient with Type 1 diabetesS Lablanche, I Debaty, E Renard, et al.
Transplantation Proceedings|August 1, 1995
One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survivalF Bayle, D Masson, P Zaoui, et al.
Transplantation Proceedings|September 24, 1998
Anti-HLA class I reimmunization after one HLA semi-identical blood transfusion in non-naive patients on a waiting list for a first renal allograftD Masson, F Bayle, C Vichier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 4, 2004
A case of arthritis caused by cytomegalovirus after kidney transplantationC Contamin, J P Brion, F Bayle, et al.
La Nouvelle Presse Medicale|September 16, 1978
[Massive plasmapheresis in the treatment of acute graft rejection resistant to usual treatment]P Vialtel, F Chenaise, E Dechelette, et al.
Intensive Care Medicine|November 27, 2008
Thrombosis during lepirudin therapy: a case reportF Wallet, F Bayle, V Leray, et al.
Nephrologie|January 1, 1985
[Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology]D Cordonnier, F C Vert-Pré, F Bayle, et al.
Presse Medicale (Paris, France : 1983)|April 28, 1984
[Nephrotoxicity of antitumor chemotherapy]D Cordonnier, J L Alix, R Schaerer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2013
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysisP Gorwood, F Bayle, G Vaiva, et al.
Presse Medicale (Paris, France : 1983)|January 12, 1985
[Apropos of the nephrotoxicity of antitumoral drug therapy]D Cordonnier, J L Alix, R Schaerer, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Diabetic Medicine : a Journal of the British Diabetic Association|September 2, 2009
Dramatic improvement of glucose control after plasmapheresis and prednisone in a patient with Type 1 diabetesS Lablanche, I Debaty, E Renard, et al.
Transplantation Proceedings|August 1, 1995
One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survivalF Bayle, D Masson, P Zaoui, et al.
Transplantation Proceedings|September 24, 1998
Anti-HLA class I reimmunization after one HLA semi-identical blood transfusion in non-naive patients on a waiting list for a first renal allograftD Masson, F Bayle, C Vichier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 4, 2004
A case of arthritis caused by cytomegalovirus after kidney transplantationC Contamin, J P Brion, F Bayle, et al.
La Nouvelle Presse Medicale|September 16, 1978
[Massive plasmapheresis in the treatment of acute graft rejection resistant to usual treatment]P Vialtel, F Chenaise, E Dechelette, et al.
Intensive Care Medicine|November 27, 2008
Thrombosis during lepirudin therapy: a case reportF Wallet, F Bayle, V Leray, et al.
Nephrologie|January 1, 1985
[Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology]D Cordonnier, F C Vert-Pré, F Bayle, et al.
Presse Medicale (Paris, France : 1983)|April 28, 1984
[Nephrotoxicity of antitumor chemotherapy]D Cordonnier, J L Alix, R Schaerer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2013
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysisP Gorwood, F Bayle, G Vaiva, et al.
Presse Medicale (Paris, France : 1983)|January 12, 1985
[Apropos of the nephrotoxicity of antitumoral drug therapy]D Cordonnier, J L Alix, R Schaerer, et al.
Pageof 7